Lilly Opts for Animal-Drugs Spinoff Instead of Selling Unit

Lilly Opts for Animal-Drugs Spinoff Instead of Selling Unit

BLOOMBERG By Jared S. Hopkins and Karen Lin, July 24, 2918   Eli Lilly & Co. will spin off its animal-health unit Elanco, focusing the company completely on drugs for people after a months-long review of the veterinary and agriculture business. The drugmaker said...